These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 127455)

  • 21. Glomerular basement membrane--reactive antibody in anti-lymphocyte globulin.
    Wilson CB; Dixon FJ; Fortner JG; Cerilli GJ
    J Clin Invest; 1971 Jul; 50(7):1525-35. PubMed ID: 4996886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal and skin xenografts from baboons to macaques: effect of antilymphocyte globulins.
    Dubernard JM; Bonneau M; Bomel J; Montagard J; Blitz M; Latour M; Blanc-Brunat N; Fries D; Brochard JC; Bansillon V; Bansillon G; Capodicasa G
    Transplant Proc; 1971 Mar; 3(1):545-50. PubMed ID: 4999462
    [No Abstract]   [Full Text] [Related]  

  • 23. Whole antilymphocyte serum: a potent safe immunosuppressive agent for intravenous use in man.
    Levey RH; Parkman R
    Transplant Proc; 1977 Mar; 9(1):1019-22. PubMed ID: 405764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with antilymphocyte globulin in 144 renal transplant recipients.
    Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE
    Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated immunity and serum blocking factor in tolerance produced in mice with antilymphocyte serum and bone marrow cell infusion.
    Wood ML; Gozzo JJ; Heppner G; Monaco AP
    Transplant Proc; 1972 Sep; 4(3):383-9. PubMed ID: 4263511
    [No Abstract]   [Full Text] [Related]  

  • 26. Potency testing of anti-lymphocyte globulins: in vitro alternatives for the monkey skin graft assay.
    Conrad C; Janssen O; Schäffner G; Kabelitz D
    Dev Biol Stand; 1999; 101():113-8. PubMed ID: 10566783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppression by antihuman lymphocyte globulin: correlation of human and animal assay systems with clinical results.
    Simmons RL; Moberg AW; Gewurz H; Soll R; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):745-8. PubMed ID: 4999469
    [No Abstract]   [Full Text] [Related]  

  • 28. New experiences with antilymphocyte globulin in human organ transplantation.
    Largiadér F; Ruckert R
    Postgrad Med J; 1976; 52(5 Suppl):79-81. PubMed ID: 792852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical factors in the quality control of antilymphocyte globulin (ALG).
    Thomas F; Thomas J; Millington G; Doane J; Mendez-Picon G; Lee HM
    Proc Clin Dial Transplant Forum; 1977; 7():134-40. PubMed ID: 98763
    [No Abstract]   [Full Text] [Related]  

  • 30. The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients.
    Amemiya H; Yokoyama T; Putnam CW; Torisu M; Starzl TE
    Clin Exp Immunol; 1972 Mar; 10(3):417-26. PubMed ID: 4556008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged rhesus skin allograft survival produced by antihuman thymocyte serum.
    Darrow CC; LaFontaine GS; Smith JJ; Martin DP; Sell KW; Kayhoe DE
    Transplant Proc; 1971 Mar; 3(1):730-2. PubMed ID: 4999466
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
    Monaco AP; Franco DJ
    Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
    [No Abstract]   [Full Text] [Related]  

  • 33. Antihuman lymphoblast globulin.
    Najarian JS; Simmons RL; Gewurz H; Moberg A; Merkel F; Moore GE
    Fed Proc; 1970; 29(1):197-201. PubMed ID: 4189495
    [No Abstract]   [Full Text] [Related]  

  • 34. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro studies on the mechanism of action of human antithymocyte globulin.
    Thomas JM; Thomas F; Williams E; Scott J
    Proc Clin Dial Transplant Forum; 1977; 7():141-7. PubMed ID: 98764
    [No Abstract]   [Full Text] [Related]  

  • 36. [Advantages of highly purified antilymphocyte globulin].
    Carraz M
    Laval Med; 1970 Feb; 41(2):243-7. PubMed ID: 4102119
    [No Abstract]   [Full Text] [Related]  

  • 37. Specific unresponsiveness to skin allografts in mice. II. The mechanism of unresponsiveness induced by tissue extracts and antilymphocytic serum.
    Kilshaw PJ; Brent L; Thomas AV
    Transplantation; 1974 Jan; 17(1):57-69. PubMed ID: 4148889
    [No Abstract]   [Full Text] [Related]  

  • 38. Positive direct antiglobulin tests with antilymphocyte globulin.
    Lapinid IM; Steib MD; Noto TA
    Am J Clin Pathol; 1984 Apr; 81(4):514-7. PubMed ID: 6702755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanism of action of heterologous anti-lymphocyte sera. I. "In vitro" activity and their effects on different aspects of immunity in rats.
    Kahan A; Jouanneau M; Brouilhet H; Delbarre F; Charles A
    Biomedicine; 1973 Jan; 18(1):69-77. PubMed ID: 4576461
    [No Abstract]   [Full Text] [Related]  

  • 40. Stability studies on horse antithymocyte globulin.
    Parcells AJ; Ko H; Royer ME; Woody JN
    Transplantation; 1977 Feb; 23(2):149-52. PubMed ID: 402045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.